Post hoc analysis provides new insights on sacubitril/valsartan in myocardial infarction
Sacubitril/valsartan is superior to ramipril in high-risk survivors of acute myocardial infarction, according to a post hoc win ratio analysis of the PARADISE-MI trial presented in a Hot Line session on 29 August at ESC Congress ...
Aug 29, 2022
0
54